WallStreetZenWallStreetZen

Stock ScreenerStock IdeasHigh Risk, High Reward
High Risk, High Reward Stocks
Speculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!

Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
Ticker
Company
Performance Score
Market Cap
Revenue
EBITDA
Earnings
EPS
Revenue Growth Y/Y
Revenue Growth 5Y
Earnings Growth Y/Y
Earnings Growth 5Y
Earnings Date
GMDA
GAMIDA CELL LTD
$9.09M$1.78M-$60.97M-$63.00M-$0.57N/AN/AN/AN/A2024-05-07
IQ
IQIYI INC
$3.87B$4.43B$1.48B$267.43M$0.288.05%4.45%N/AN/A2024-05-14
INTZ
INTRUSION INC
$4.78M$5.69M-$12.51M-$16.27M-$15.20-26.40%-9.52%N/AN/A2024-05-09
PPBT
PURPLE BIOTECH LTD
$12.12M$0.00$22.27M$19.88MN/AN/A-100.00%N/AN/A2024-05-09
GOEV
CANOO INC
$102.63M$519.00k-$330.48M-$353.81M-$16.79N/AN/AN/AN/A2024-03-28
ASLN
ASLAN PHARMACEUTICALS LTD
$10.85M$12.00MN/A-$45.19M-$2.75N/AN/AN/AN/A2024-04-26
CLNN
CLENE INC
$54.58M$654.00k-$42.81M-$49.50M-$0.4738.27%N/AN/AN/A2024-05-10
ACRS
ACLARIS THERAPEUTICS INC
$89.37M$31.25M-$87.99M-$88.48M-$1.275.03%38.41%N/AN/A2024-05-06
LIFE
ATYR PHARMA INC
$135.50M$353.00k-$47.65M-$50.39M-$0.94-96.60%N/AN/AN/A2024-05-07
KZR
KEZAR LIFE SCIENCES INC
$65.74M$7.00M-$99.25M-$101.87M-$1.40N/AN/AN/AN/A2024-05-09
AGEN
AGENUS INC
$232.92M$156.31M-$134.25M-$245.97M-$0.6959.47%33.56%N/AN/A2024-05-07
APTO
APTOSE BIOSCIENCES INC
$23.58M$0.00-$50.74M-$51.21M-$7.58N/AN/AN/AN/A2024-05-06
EYEN
EYENOVIA INC
$46.72M$3.79k-$24.11M-$27.26M-$0.66N/AN/AN/AN/A2024-05-09
OCUP
OCUPHIRE PHARMA INC
$50.12M$19.05M-$9.97M-$9.99M-$0.46-52.20%N/AN/AN/A2024-03-28
CKPT
CHECKPOINT THERAPEUTICS INC
$72.80M$103.00k-$51.85M-$51.85M-$3.17-46.35%-50.61%N/AN/A2024-03-28
SONN
SONNET BIOTHERAPEUTICS HOLDINGS INC
$6.23M$129.18k-$14.38M-$14.46M-$9.87-49.81%-66.53%N/AN/A2024-05-08
IFRX
INFLARX NV
$90.68M$68.58k-$45.72M-$46.38M-$0.85N/AN/AN/AN/A2024-05-09
BNOX
BIONOMICS LIMITED
$11.90M$14.50kN/A-$20.40M$32.92-91.52%N/A261.25%N/A
SYBX
SYNLOGIC INC
$20.73M$3.37M-$51.97M-$57.28M-$8.81185.68%5.99%N/AN/A2024-05-09
AADI
AADI BIOSCIENCE INC
$58.19M$24.35M-$64.90M-$65.77M-$2.4460.06%3.85%N/AN/A2024-05-08
GOSS
GOSSAMER BIO INC
$263.93M$0.00-$161.92M-$179.82M-$1.18N/AN/AN/AN/A2024-05-07
MIST
MILESTONE PHARMACEUTICALS INC
$95.67M$1.00M-$57.04M-$59.69M-$1.39-80.00%N/AN/AN/A2024-05-09
GEVO
GEVO INC
$175.56M$17.20M-$45.05M-$66.22M-$0.281,363.83%-12.15%N/AN/A2024-05-08
HOOK
HOOKIPA PHARMA INC
$71.24M$20.13M-$77.34M-$81.58M-$0.8641.27%21.41%N/AN/A2024-05-09
LUMO
LUMOS PHARMA INC
$22.86M$2.05M-$34.02M-$34.03M-$4.1834.67%-30.31%N/AN/A2024-05-01
INAB
IN8BIO INC
$52.38M$0.00-$27.51M-$30.01M-$1.00N/AN/AN/AN/A2024-05-10
SPRB
SPRUCE BIOSCIENCES INC
$30.45M$10.09M-$47.14M-$47.92M-$1.24N/AN/AN/AN/A2024-05-13
FEMY
FEMASYS INC
$31.82M$1.09M-$11.83M-$12.73M-$0.97-10.86%N/AN/AN/A2024-05-09
PASG
PASSAGE BIO INC
$72.83M$0.00-$98.34M-$102.06M-$1.86N/AN/AN/AN/A2024-05-09
CMPS
COMPASS PATHWAYS PLC
$610.16M$0.00-$113.21M-$118.46M-$2.32N/AN/AN/AN/A2024-05-06
PGEN
PRECIGEN INC
$360.93M$6.23M-$89.23M-$95.90M-$0.39-76.87%-47.16%N/AN/A2024-05-08
IKNA
IKENA ONCOLOGY INC
$67.08M$9.16M-$65.59M-$68.17M-$1.63-41.35%N/AN/AN/A2024-05-13
PRST
PRESTO AUTOMATION INC
$15.51M$21.20M-$48.24M-$66.42M-$1.31-30.61%N/AN/AN/A2024-05-16
TPST
TEMPEST THERAPEUTICS INC
$82.33M$0.00-$25.96M-$29.49M-$1.91N/AN/AN/AN/A2024-05-08
LUXH
LUXURBAN HOTELS INC
$55.25M$98.83M-$3.52M-$32.98M-$1.12159.26%N/AN/AN/A2024-05-07
VOR
VOR BIOPHARMA INC
$150.65M$0.00-$109.64M-$117.86M-$1.75N/AN/AN/AN/A2024-05-09
IMRX
IMMUNEERING CORP
$71.16M$0.00-$52.71M-$53.47M-$1.88-100.00%N/AN/AN/A2024-05-07
YTEN
YIELD10 BIOSCIENCE INC
$4.49M$147.00k-$13.79M-$14.49M-$2.48-71.46%-22.48%N/AN/A2024-05-08
RGF
REAL GOOD FOOD COMPANY INC
$12.63M$156.38M$5.29M-$15.18M-$2.0718.88%N/AN/AN/A2024-05-10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.